Leah Kuntz

The US Food and Drug Administration has approved a new medication for the treatment of insomnia.

In the face of opposition from doctors, clinics, and courts, Victor Escobar became the first Colombian to die via euthanasia on Friday January 7, 2022.

The new Studio Lab at Northwestern University School of Communication aims to fight stigma by providing positive depictions of mental health in media.

Representative Jason Ortitay and Senator Steve Santarsiero have introduced legislation to help increase awareness of eating disorders in children.

The supplemental new drug application of brexpiprazole for the treatment of schizophrenia in pediatric patients aged 13 to 17 received FDA approval.

The FDA authorized the marketing of these tobacco products that help reduce exposure to and consumption of nicotine for smokers.

Are common genes and signaling pathways involved in PTSD and migraine?

Leading medical organizations support policies requiring COVID-19 vaccination.

Data from a clinical program evaluating the efficacy and safety of zuranolone was presented at the American College of Neuropsychopharmacology Congress. What new developments did they share?

Psychiatric Times, your go-to source for what is relevant and important in the field, is pleased to share the following highlights from the 2021 Neuroscience Education Institute Congress.

Individuals with ADHD are 4 times more likely to have generalized anxiety disorder at some point in their life.

The Chief Medical Officer for the American Foundation for Suicide Prevention sat down to talk with Psychiatric Times about the new data on suicide deaths between 2019 and 2020.

Two transgender women in North Carolina are facing struggles in getting prisons to acknowledge their gender identity. What does this say about care for incarcerated transgender individuals in general?

Negative symptoms of schizophrenia are associated with higher overall morbidity and decreased functioning. These study results offer hope.

A coalition of 240 organizations came together to urge Congress to pass legislation to fight the opioid crisis.

The American Academy of Neurology issued a position statement for mental health professionals, warning them to carefully discuss the benefits and known harms of aducanumab.

Cranberry sauce and clinical pearls: the most delicious of combos. Check out more of our November issue.

Need a recap of the custom Around the Practice video program on bipolar disorder? We've got you covered.

A new study examined the relationship between ADHD and oppositional defiant and conduct disorder, callous-unemotional traits, and reward-related inhibitory control.

Treatment-resistant depression: how to diagnose, what treatment options are available, and how to best help patients.

The FDA has approved Dyanavel XR, extended release once-daily tablets for the treatment of attention-deficit/hyperactivity disorder.

How can you provide affirmative mental health care for transgender and gender diverse patients?

Benzodiazepines: a class of medications that evokes that a visceral reaction.

Here’s how to integrate treatment strategies that address both ADHD and comorbid conditions.

Did you miss the Annual Psychiatric Times World CME Conference? Don't worry, we've got you covered.

Can mindfulness be an additional therapy to help treat ADHD in children?

Three leading groups in child and adolescent mental health have declared a state of emergency for the nation’s youth.

One man shares his suicide survival story, and what he does to aid suicide prevention.

Nearly 80% of eating disorders go undetected. What screening tools can help identify them?

PH94B for the treatment of social anxiety disorder further differentiates its mechanism of action from benzodiazepines in a new lab rat preclinical study.